Nama Insights

State Street SPDR S&P Pharmaceuticals ETF (XPH)

Health · State Street Investment Management · NYSE

HealthETF
State Street SPDR S&P Pharmaceuticals ETF (XPH) is an exchange-traded fund in the Health category. It has $428.43M in assets, an expense ratio of 0.35% and a 0.51% dividend yield. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
Assets under management$428.43M
Expense ratio0.35%
CategoryHealth
Dividend yield0.51%
NAV$67.97
Fund familyState Street Investment Management
ExchangeNYSE

Top holdings

The largest positions State Street SPDR S&P Pharmaceuticals ETF reports, by weight.

HoldingNameWeight
DFTX Definium Therapeutics Inc Ordinary Shares 3.09%
MBX MBX Biosciences Inc 2.72%
ALMS Alumis Inc 2.14%
ATAI AtaiBeckley Inc 2.13%
TRVI Trevi Therapeutics Inc 2.12%
ELVN Enliven Therapeutics Inc 2.09%
AMLX Amylyx Pharmaceuticals Inc 2.04%
MANE Veradermics Inc 2.02%
LGND Ligand Pharmaceuticals Inc 1.94%
NUVB Nuvation Bio Inc Ordinary Shares - Class A 1.89%

Other Health ETFs

Explore live XPH data on Nama Insights →